Phase I study of FR901228 [romidepsin] in patients with recurrent or refractory chronic lymphocytic leukemia, small lymphocytic lymphoma, or acute myeloid leukemia
Phase of Trial: Phase I
Latest Information Update: 23 Aug 2005
At a glance
- Drugs Romidepsin (Primary)
- Indications Acute myeloid leukaemia; Chronic lymphocytic leukaemia
- Focus Adverse reactions
- 23 Aug 2005 New trial record.